glp 1 and exercise Media Centre Rethinking Exercise on GLP-1 Medications:
Description
It is not suitable for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis
Research shows that semaglutide users experience an average LDL reduction of 510% and triglyceride improvements, making it a dual-action therapy for metabolic health
2022;95:6071.e12
At MTC, we don't believe in automatically pushing patients to the newest drug if their current regimen is already working
doi: 10.1056/NEJMc1614624
